These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 3362274

  • 1. Reduced incidence of hyperkalemia and azotemia in patients receiving sulindac compared with indomethacin.
    Nesher G, Zimran A, Hershko C.
    Nephron; 1988; 48(4):291-5. PubMed ID: 3362274
    [Abstract] [Full Text] [Related]

  • 2. Hyperkalemia associated with sulindac therapy.
    Nesher G, Zimran A, Hershko C.
    J Rheumatol; 1986 Dec; 13(6):1084-5. PubMed ID: 3560096
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Indomethacin-associated hyperkalemia in the elderly.
    Meier DE, Myers WM, Swenson R, Bennet WM.
    J Am Geriatr Soc; 1983 Jun; 31(6):371-3. PubMed ID: 6853948
    [No Abstract] [Full Text] [Related]

  • 5. Sulindac. A potentially renal-sparing nonsteroidal anti-inflammatory drug.
    Bunning RD, Barth WF.
    JAMA; 1982 Dec 03; 248(21):2864-7. PubMed ID: 7143649
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Sulindac in ankylosing spondylitis. Double-blind evaluation of sulindac and indomethacin.
    Calin A, Britton M.
    JAMA; 1979 Oct 26; 242(17):1885-6. PubMed ID: 480622
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A double-blind study comparing sulindac with indomethacin in rheumatoid arthritis.
    Lund HI, Donde R, Petersen PH.
    Scand J Rheumatol Suppl; 1980 Oct 26; 37():1-6. PubMed ID: 7013055
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Coadministration of estradiol/drospirenone and indomethacin does not cause hyperkalemia in healthy postmenopausal women: a randomized open-label crossover study.
    Schütt B, Kunz M, Blode H.
    J Clin Pharmacol; 2007 Jun 26; 47(6):774-81. PubMed ID: 17463217
    [Abstract] [Full Text] [Related]

  • 12. The influence of selective and nonselective prostaglandin inhibition on renin.
    Pedrinelli R, Magagna A, Abdel-Haq B, Salvetti A.
    Adv Prostaglandin Thromboxane Leukot Res; 1985 Jun 26; 13():147-50. PubMed ID: 3159197
    [Abstract] [Full Text] [Related]

  • 13. Indomethacin-induced azotaemia and hyperkalaemia: a case study.
    Nicholls MG, Espiner EA.
    N Z Med J; 1981 Nov 25; 94(696):377-9. PubMed ID: 7033849
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hyperkalemia associated with indomethacin.
    Goldszer RC, Coodley EL, Rosner MJ, Simons WM, Schwartz AB.
    Arch Intern Med; 1981 May 25; 141(6):802-4. PubMed ID: 7016059
    [Abstract] [Full Text] [Related]

  • 17. Histological study of the effects of three anti-inflammatory preparations on the gastric mucosa.
    McIntyre RL, Irani MS, Piris J.
    J Clin Pathol; 1981 Aug 25; 34(8):836-42. PubMed ID: 7276205
    [Abstract] [Full Text] [Related]

  • 18. Effects of indomethacin and sulindac on hydrochlorothiazide kinetics.
    Koopmans PP, Kateman WG, Tan Y, van Ginneken CA, Gribnau FW.
    Clin Pharmacol Ther; 1985 Jun 25; 37(6):625-8. PubMed ID: 3891188
    [Abstract] [Full Text] [Related]

  • 19. Renal failure and nephrotic syndrome associated with sulindac.
    Champion de Crespigny PJ, Becker GJ, Ihle BU, Walter NM, Wright CA, Kincaid-Smith P.
    Clin Nephrol; 1988 Jul 25; 30(1):52-5. PubMed ID: 3208459
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.